![Patrick Chaltin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Patrick Chaltin
Director/Miembro de la Junta en Cytura Therapeutics BV .
Perfil
Patrick Chaltin is currently a Director at Cytura Therapeutics BV.
He previously worked as a Non-Executive Director at Aratana Therapeutics NV.
He holds a doctorate degree from Katholieke Universiteit Leuven.
Cargos activos de Patrick Chaltin
Empresas | Cargo | Inicio |
---|---|---|
Cytura Therapeutics BV
![]() Cytura Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Cytura Therapeutics BV is a Dutch company that focuses on finding a solution to stop destabilization of the genome. The company is based in Oss, Netherlands. The company aims to target genomic instability as a stand-alone therapy or in combination therapy to avoid therapy resistance or relapse, which will help make cancer treatment more effective and improve the lives of patients worldwide. The company was founded by Ad W. van Gorp, who has been the CEO since incorporation. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Patrick Chaltin.
Empresas | Cargo | Fin |
---|---|---|
Aratana Therapeutics NV
![]() Aratana Therapeutics NV Pharmaceuticals: OtherHealth Technology Aratana Therapeutics NV engages in the development and marketing of veterinary medicine. It offers Entyce, nocita, and Galliprant. The company was founded on December 20, 2007 and is headquartered in Leuven, Belgium. | Director/Miembro de la Junta | - |
Formación de Patrick Chaltin.
Katholieke Universiteit Leuven | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Aratana Therapeutics NV
![]() Aratana Therapeutics NV Pharmaceuticals: OtherHealth Technology Aratana Therapeutics NV engages in the development and marketing of veterinary medicine. It offers Entyce, nocita, and Galliprant. The company was founded on December 20, 2007 and is headquartered in Leuven, Belgium. | Health Technology |
Cytura Therapeutics BV
![]() Cytura Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Cytura Therapeutics BV is a Dutch company that focuses on finding a solution to stop destabilization of the genome. The company is based in Oss, Netherlands. The company aims to target genomic instability as a stand-alone therapy or in combination therapy to avoid therapy resistance or relapse, which will help make cancer treatment more effective and improve the lives of patients worldwide. The company was founded by Ad W. van Gorp, who has been the CEO since incorporation. | Commercial Services |
- Bolsa de valores
- Insiders
- Patrick Chaltin